Clinical Trial Update: Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating EL219 versus standard of care for early antifungal therapy in patients with suspected invasive mould infections, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection

Drugs mentioned

• EL219

Snippet

Sponsor: Elion Therapeutics, Inc. | Conditions: Suspected Invasive Mould Infection | Phase 2 | Status: RECRUITING